Notícies

02/05/2013

Oryzon to Present its LSD1 programs in Acute Leukemias and in Neurodegenerative disorders at the GTC’s 3rd Epigenetics in Drug Discovery conference in Boston



Notícies: 1-1 / 1

Subscriu-te a les nostres notícies

Arxiu

2013